Order Article Reprints

Scicali R, Mandraffino G, Scuruchi M, Lo Gullo A, Di Pino A, Ferrara V, Morace C, Aragona CO, Squadrito G, Purrello F, et al. Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid Units. Biomedicines. 2022; 10(7):1715. https://doi.org/10.3390/biomedicines10071715

Scicali, Roberto, Giuseppe Mandraffino, Michele Scuruchi, Alberto Lo Gullo, Antonino Di Pino, Viviana Ferrara, Carmela Morace, Caterina Oriana Aragona, Giovanni Squadrito, Francesco Purrello, and et al. 2022. "Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid Units" Biomedicines 10, no. 7: 1715. https://doi.org/10.3390/biomedicines10071715

Scicali, R., Mandraffino, G., Scuruchi, M., Lo Gullo, A., Di Pino, A., Ferrara, V., Morace, C., Aragona, C. O., Squadrito, G., Purrello, F., & Piro, S. (2022). Effects of Lipid Lowering Therapy Optimization by PCSK9 Inhibitors on Circulating CD34+ Cells and Pulse Wave Velocity in Familial Hypercholesterolemia Subjects without Atherosclerotic Cardiovascular Disease: Real-World Data from Two Lipid Units. Biomedicines, 10(7), 1715. https://doi.org/10.3390/biomedicines10071715